Signify Health, Inc.
SGFY · NYSE
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.11 | -0.00 | 0.32 |
| FCF Yield | 1.42% | 0.99% | -0.53% | -1.30% |
| EV / EBITDA | 39.34 | -23.00 | 26.02 | 662.51 |
| Quality | ||||
| ROIC | 9.32% | -3.55% | 2.57% | -0.52% |
| Gross Margin | 63.10% | 11.80% | 48.13% | 47.11% |
| Cash Conversion Ratio | 0.12 | -0.26 | 0.01 | 1.98 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.78% | 12.51% | 28.69% | 45.12% |
| Free Cash Flow Growth | 39.88% | 501.56% | 68.63% | 30.96% |
| Safety | ||||
| Net Debt / EBITDA | -0.83 | 0.44 | -0.81 | -19.15 |
| Interest Coverage | 20.93 | -9.47 | 9.00 | -3.78 |
| Efficiency | ||||
| Inventory Turnover | 0.62 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 214.99 | 155.85 | 138.80 | 141.72 |